News headlines about Ventas (NYSE:VTR) have been trending positive recently, Accern reports. The research group scores the sentiment of media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Ventas earned a media sentiment score of 0.26 on Accern’s scale. Accern also assigned media coverage about the real estate investment trust an impact score of 46.1107119835348 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.
Here are some of the news headlines that may have impacted Accern’s rankings:
- Review of Financial analysis: Public Joint-Stock Company Mobile TeleSystems, (NYSE: MBT), Ventas, Inc., (NYSE: VTR) (nysetradingnews.com)
- Rotating into Defensives? Ventas, Inc. (VTR), Louisiana-Pacific Corporation (LPX) (nmsunews.com)
- Investors Are Watching the Indicators on Shares of Ventas Inc (VTR) (baycityobserver.com)
- By The Book: Delving into Shares of Ventas, Inc. (NYSE:VTR) (baycityobserver.com)
- Traders Watch List: Teva Pharmaceutical Industries Limited, (NYSE: TEVA), Ventas, Inc., (NYSE: VTR) (globalexportlines.com)
Several research firms have commented on VTR. Cantor Fitzgerald reaffirmed a “hold” rating and issued a $56.00 target price on shares of Ventas in a research note on Friday, July 27th. ValuEngine raised shares of Ventas from a “strong sell” rating to a “sell” rating in a research note on Thursday, June 28th. Royal Bank of Canada set a $61.00 target price on shares of Ventas and gave the stock a “buy” rating in a research note on Tuesday, July 31st. Jefferies Financial Group reaffirmed a “$57.33” rating and issued a $61.00 target price on shares of Ventas in a research note on Wednesday, July 18th. Finally, Bank of America lifted their target price on shares of Ventas from $55.00 to $60.00 and gave the stock a “neutral” rating in a research note on Tuesday, July 10th. Five investment analysts have rated the stock with a sell rating, ten have given a hold rating and three have issued a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average price target of $57.07.
Ventas (NYSE:VTR) last announced its quarterly earnings results on Friday, July 27th. The real estate investment trust reported $1.08 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.02 by $0.06. The company had revenue of $942.30 million for the quarter, compared to analyst estimates of $919.95 million. Ventas had a net margin of 34.00% and a return on equity of 5.02%. Ventas’s revenue for the quarter was up 5.2% on a year-over-year basis. During the same quarter last year, the business earned $0.42 EPS. sell-side analysts forecast that Ventas will post 4.04 earnings per share for the current fiscal year.
In other Ventas news, Chairman Debra A. Cafaro sold 15,439 shares of Ventas stock in a transaction on Wednesday, May 30th. The shares were sold at an average price of $55.00, for a total value of $849,145.00. Following the transaction, the chairman now owns 759,606 shares in the company, valued at approximately $41,778,330. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Chairman Debra A. Cafaro sold 30,942 shares of Ventas stock in a transaction on Tuesday, July 3rd. The shares were sold at an average price of $58.00, for a total transaction of $1,794,636.00. Following the transaction, the chairman now owns 775,109 shares in the company, valued at approximately $44,956,322. The disclosure for this sale can be found here. In the last quarter, insiders sold 61,886 shares of company stock worth $3,496,556. 1.40% of the stock is owned by company insiders.
Ventas, Inc, an S&P 500 company, is a leading real estate investment trust. Its diverse portfolio of more than 1,200 assets in the United States, Canada and the United Kingdom consists of seniors housing communities, medical office buildings, life science and innovation centers, inpatient rehabilitation and long-term acute care facilities, health systems and skilled nursing facilities.
Featured Story: Fundamental Analysis and Choosing Stocks
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.